Endothelial Effects of Basal Insulin: Detemir Versus Glargine
Condition(s):Type 2 Diabetes; Endothelial Dysfunction; Cardiovascular DiseaseLast Updated:August 17, 2010Completed
Hide Studies Not Open or Pending
Condition(s):Type 2 Diabetes; Endothelial Dysfunction; Cardiovascular DiseaseLast Updated:August 17, 2010Completed
Condition(s):Type 2 Diabetes Mellitus; Coronary Artery DiseaseLast Updated:March 5, 2021Completed
Condition(s):Endothelial Dysfunction; Childhood ObesityLast Updated:August 7, 2019Completed
Condition(s):Diabetes MellitusLast Updated:October 11, 2018Completed
Condition(s):Corneal Edema; Fuchs Dystrophy; Fuchs’ Endothelial Dystrophy; Pseudophakic Bullous Keratopathy; Corneal Endothelial Dystrophy; Corneal Transplant FailureLast Updated:December 10, 2019Unknown status
Condition(s):Diabetes Mellitus Type 2Last Updated:May 15, 2018Completed
Condition(s):Sleep Apnea, ObstructiveLast Updated:March 21, 2024Recruiting
Condition(s):Corneal Endothelial Changes After PhacoemulsificationLast Updated:June 22, 2022Recruiting
Condition(s):Cardiovascular DiseaseLast Updated:January 29, 2024Completed
Condition(s):Endothelial Function; Platelet AggregationLast Updated:August 11, 2009Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.